Adenosine: A key player in neuroinflammation
Authors:
Open Access
- 25 March 2025
- journal article
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (4) , 1556-1557
Abstract
An abstract is unavailable. This article is available as a PDF only.Keywords
This publication has 13 references indexed in Scilit:
- Adenosine triggers early astrocyte reactivity that provokes microglial responses and drives the pathogenesis of sepsis-associated encephalopathy in miceNature Communications, 2024
- Extracellular Purine Metabolism—Potential Target in Multiple SclerosisMolecular Neurobiology, 2024
- FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosisCell Reports, 2023
- Drugs targeting adenosine signaling pathways: A current viewBiomedicine & Pharmacotherapy, 2023
- CD73-derived adenosine controls inflammation and neurodegeneration by modulating dopamine signallingBrain, 2019
- Pathological overproduction: the bad side of adenosineBritish Journal of Pharmacology, 2017
- A 2B adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathwayPharmacological Research, 2017
- Cytokine networks in neuroinflammationNature Reviews Immunology, 2016
- Genetic inactivation of the adenosine A2A receptor exacerbates brain damage in mice with experimental autoimmune encephalomyelitisJournal of Neurochemistry, 2012
- CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitisProceedings of the National Academy of Sciences, 2008